874492-44-1

Basic information

• Product Name: 2-(2-methoxy-ethoxy)-5-nitro-pyridine
• Synonyms: 2-(2-methoxy-ethoxy)-5-nitro-pyridine
• CAS NO: 874492-44-1
• Molecular Formula: C8H10N2O4
• Molecular Weight: 198
• Mol File: 874492-44-1.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(2-methoxy-ethoxy)-5-nitro-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-methoxy-ethoxy)-5-nitro-pyridine(874492-44-1)
• EPA Substance Registry System: 2-(2-methoxy-ethoxy)-5-nitro-pyridine(874492-44-1)

Safety Data

• Hazardous Substances Data: 874492-44-1(Hazardous Substances Data)

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 3139-99-9 sodium 2-methoxyethanolate 
• 23056-36-2 2-chloro-4-nitropyridine 
• 109-86-4 2-methoxy-ethanol 
• 5418-51-9 5-nitro-2-hydroxypyridine 

Downstream Products

• 1419604-17-3 phenyl 6-(2-hydroxyethoxy)pyridin-3-ylcarbamate 
• 1419604-14-0 phenyl 6-(2-methoxyethoxy)pyridin-3-ylcarbamate 
• 874491-83-5 6-(2-methoxyethoxy)pyridin-3-ylamine 
• 1419600-93-3 1-((1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-3-(6-(2-methoxyethoxy)pyridin-3-yl)urea 
• 1419600-90-0 1-((3-tert-butyl-1-(3-chlorophenyl)-1H-pyrazol-5-yl)methyl)-3-(6-(2-methoxyethoxy)pyridin-3-yl)urea 

Relevant articles and documents

As tyrosine kinase inhibitors of the nitrogen-containing heteroaromatic ring derivatives

The present invention relates to compounds as represented by general formula (I) as tyrosine kinase inhibitors, preparation method thereof, pharmaceutical compositions containing the compounds, and uses thereof for preventing and/or treating instances of B-cell related leukemia, inflammatory diseases and autoimmune diseases, wherein A, ring B, L1, L2, R1, R2, R3, a, b, c, d, e, p and q are as defined in the specification.

NAPHTHALENE DERIVATIVE

The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I) (R is as defined in the description) or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.

Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands

Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also to a method of using these compounds for treating and/or inhibiting pain and further diseases and/or disorders.